This article is more than 5 years old. Information may no longer be current.
AcrySof Toric reduces cylinder, surgeon says
Click Here to Manage Email Alerts
NEW YORK — The AcrySof Toric IOL can “significantly reduce” cylinder and improve uncorrected visual acuity in patients with corneal astigmatism who are undergoing cataract surgery, according to one surgeon.
Stephen S. Lane, MD, presented data on 77 patients who were implanted with the toric version of Alcon’s acrylic IOL. Data was presented here at the Ocular Surgery News Symposium on Cataract, Glaucoma and Refractive Surgery.
Patients were randomly assigned to receive the Alcon AcrySof Toric (SA60TT) or a control nontoric lens (AcrySof SA60AT). At 80 to 100 days postoperative, 78% of patients implanted with the SA60TT were 20/20 or better uncorrected, compared to 68% of patients implanted with the SA60AT.
No lens-related adverse events were reported, Dr. Lane said. Nonlens-related adverse events reported with the SA60TT included iris damage due to IOL exchange (one patient); cystoid macular edema (three patients); and secondary surgical intervention (two patients), which included laser to repair retinal hole and an anterior chamber paracentesis to lower intraocular pressure. In patients implanted with the SA60AT, nonlens-related adverse events included cystoid macular edema (one patient) and secondary surgical intervention (one patient), which included removal of retained lens fragment.
Dr. Lane said the toric lens is undergoing further clinical analysis to demonstrate safety and effectiveness.